NCT07075666

Early Detection of Prostate Cancer of Syrian Men

Early Detection of Prostate Cancer Among Men in the Middle Region of Syria

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 1,000 (estimated)
• Sponsor: Al-Hawash Private University · Academic / Other
• Sex: Male
• Age: 40 Years – 65 Years
• Healthy volunteers: —

Summary

Prostate cancer is a significant health concern in the Middle East, including Syria, where many cases are diagnosed at advanced stages due to low awareness and inadequate screening practices. The mortality-to-incidence ratio for prostate cancer in the region is alarmingly high, indicating a pressing need for effective early detection strategies.

Detailed description

This study aims to assess the awareness, attitudes, and practices regarding prostate cancer screening among men in the middle region of Syria, with the goal of identifying barriers to early detection and informing public health interventions.

Conditions

• the Detection of Prostate Cancer in Men

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	PSA	Prostate-Specific Antigen test, a blood test used to measure the level of PSA in a man's blood. PSA is a protein produced by the prostate gland, and elevated levels can indicate various conditions, including prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis.
DIAGNOSTIC_TEST	DRE	A digital rectal exam (DRE) is a procedure where a doctor inserts a lubricated, gloved finger into the rectum to check for abnormalities.

Timeline

• Start date: 2025-05-17
• Primary completion: 2025-05-31
• Completion: 2025-07-30
• First posted: 2025-07-20
• Last updated: 2025-07-20

Locations

1 site across 1 country: Syria